跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Dalasave
Approved
STANDARD
Dalasave
Maxitech Pharma (Pvt.) Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ebd58c5b91e37cab
Company
Maxitech Pharma (Pvt.) Ltd
Type
Standard
Approval Details
Approval Id
ebd58c5b91e37cab
Drug Approval Philippines Name
Dalasave
Product Name
Dalasave
Registration Number
DRP-14203-01
Brand Name
Dalasave
Generic Name
Clindamycin (as phosphate)
Dosage Form
Solution for Injection (IM/IV)
Dosage Strength
150 mg/mL (300 mg / 2mL)
Manufacturer
Maxitech Pharma (Pvt.) Ltd
Importer
Accesspoint International Trading Inc.
Distributor
Savelink Pharma and Trading Co
Issuance Date
28 March 2024
Expiry Date
20 July 2028
Pharmacologic Category
Antibacterial (Lincosamide)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ebd58c5b91e37cab
Type
Standard
Back to Philippines FDA Approvals
Dalasave - Philippines FDA Drug Approval Details